 BEVERLY, Mass., April 14, 2021 GLOBE NEWSWIRE -- LexaGene Holdings, Inc., TSX-V: LXG; OTCQB: LXXGF the Company, a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to host a private event for a select group of veterinarians that will feature keynote speaker Dr. Shelley Rankin, Professor of Microbiology at the University of Pennsylvanias School of Veterinary Medicine Penn Vet, who will present data on her experience using LexaGenes MiQLab to detect Staphylococcus in specimens collected from canine skin infections. In addition, Dr. Jack Regan, LexaGenes CEO and Founder, will provide some introductory remarks on the use of molecular diagnostics in veterinary medicine and present some analytical and clinical data generated using LexaGenes MiQLab system. Any information thought to be of material nature for this seminar is described below. 